Plasmodium falciparum heterochromatin protein 1 binds to tri-methylated histone 3 lysine 9 and is linked to mutually exclusive expression of var genes by Pérez-Toledo, Karla et al.
2596–2606 Nucleic Acids Research, 2009, Vol. 37, No. 8 Published online 6 March 2009
doi:10.1093/nar/gkp115
Plasmodium falciparum heterochromatin protein 1
binds to tri-methylated histone 3 lysine 9 and is
linked to mutually exclusive expression of var genes
Karla Pe ´rez-Toledo
1, Ana Paola Rojas-Meza
1,2, Liliana Mancio-Silva
2,
Nora Adriana Herna ´ndez-Cuevas





2 and Rosaura Hernandez-Rivas
1,*
1Departamento de Biomedicina Molecular, Centro de Investigacio ´n y de Estudios Avanzados del Instituto
Polite ´cnico Nacional (IPN), Apartado Postal 14-740, 07360, Me ´xico D. F., Me ´xico,
2Institut Pasteur, Unite ´
de Biologie des Interactions Ho ˆte-Parasite – CNRS URA2581. 25, Rue du Dr. Roux, 75724 Paris, France and
3Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Auto ´noma de
Me ´xico. Av. de los Barrios 1, Col. Los Reyes Iztacala, Tlalnepantla, Edo. de Me ´xico, CP 54090, Me ´xico
Received December 1, 2008; Revised February 6, 2009; Accepted February 10, 2009
ABSTRACT
Increasing experimental evidence shows a promi-
nent role of histone modifications in the coordinated
control of gene expression in the human malaria
parasite Plasmodium falciparum. The search for
the histone-mark-reading machinery that translates
histone modifications into biological processes,
such as formation of heterochromatin and antigenic
variation is of foremost importance. In this work, we
identified the first member of a histone modification
specific recognition protein, an orthologue of
heterochromatin protein 1 (PfHP1). Analysis of the
PfHP1 amino-acid sequence revealed the presence
of the two characteristic HP1 domains: a chromo-
domain (CD) and a chromo shadow domain (CSD).
Recombinant CD binds to di- and tri-methylated
lysine 9 from histone H3, but not to unmodified
or methylated histone H3 in lysine 4. PfHP1 is able
to interact with itself to form dimers, underlying
its potential role in aggregating nucleosomes to
form heterochromatin. Antibodies raised against
PfHP1 detect this molecule in foci at the perinuclear
region. ChIP analysis using anti-PfHP1 shows that
this protein is linked to heterochromatin of subtelo-
meric non-coding repeat regions and monoallelic
expression of the major virulence var gene family.
This is the first report implicating an HP1 protein
in the control of antigenic variation of a protozoan
parasite.
INTRODUCTION
Plasmodium falciparum, the causal protozoan agent of the
most severe form of human malaria, has a complex life
cycle with two diﬀerent hosts, the Anopheles mosquito and
humans. In order to complete its life cycle, P. falciparum
invades diﬀerent types of cells and self-propagates in very
distinct environments in the mosquito (gut, hemolymph
and salivary glands) as well as in the human host (skin,
liver and erythrocytes). Each of these distinct environ-
ments exerts selective pressure related to morphological
changes that force P. falciparum to exhibit diﬀerential
gene expression during its life cycle (1,2). A surprising
ﬁnding was the identiﬁcation of a relatively low number
of genes encoding transcription factors in the parasite,
although the basal core transcriptional machinery and
the protein-coding genes involved in nucleosome assembly
and regulation of chromatin structure were found to
be conserved (3–5). To date, no speciﬁc DNA-binding
proteins have been identiﬁed other than PfMyb1 (6) and
the ApiAp2 gene family (7). This suggested that epigenetic
mechanisms play a signiﬁcant role in controlling gene
expression in Plasmodium (3,8–10). The importance
of reversible chromatin modiﬁcations involving histone
modiﬁcations and the chromatin-associated protein
PfSir2 was ﬁrst demonstrated for a subtelomeric gene
family (var gene family) involved in the control of anti-
genic variation in P. falciparum (10). Knock out of PfSir2
resulted in the de-repression of a fraction of the members
of the var gene family (11). A screen for histone modiﬁca-
tions revealed that H3K9me3 plays a particular role in var
gene repression (12,13) and H3K4me2/3 in transcriptional
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tone modiﬁcations occur mainly in the 50-UTR regions
of var genes. It was shown that histone modiﬁcations
also play a major role in the regulation of non-var genes
(12,14–16). The identiﬁcation of factors able to ‘read’
speciﬁc histone marks and translate them into changes
in gene activity remains elusive in Plasmodium.
In this work, we identiﬁed the ﬁrst plasmodial protein
that displays features of the histone-reading machinery
that binds speciﬁcally to H3K9me2/3. The identiﬁed
protein is an orthologue to heterochromatin protein 1
(PfHP1) and shows a speciﬁc location to perinuclear
foci. Chromatin immunoprecipitation (ChIP) assays
reveal that the PfHP1 protein is a component of subtelo-
meric chromatin. Furthermore, our data links PfHP1 to
epigenetically silenced var genes, since an active var gene
is devoid of PfHP1 in its 50-UTR.
MATERIALS AND METHODS
Parasites
Plasmodium falciparum FCR3 strain was cultivated
according to standard culture conditions (17). Panning
assays for selection of FCR3 parasites that transcribe
var genes associated with CD36 and CSA binding have
been done as previously described (18).
Recombinant proteins
A 801bp DNA fragment of the PfHP1 gene was obtained
by RT–PCR. The sequences of direct and reverse oligonu-
cleotides were: PfHP1EcoRI 50-CGGAATTCATGACGG
GTCAGATGAAGAA-30 and PfHP1XhoI 50-CCGCTCG
AGTTAAGCTGTACGGTATCTTAG-30, respectively.
The PCR fragment was digested, retrieved and inserted
into the EcoRI-XhoI-digested pGEX4T1 vector
(Amersham) fused to a GST-tag. The resulting construct
was sequenced and called GST-PfHP1. The primers
PfHP1-CDEcoRI 50-CGGAATTCATGACAGGGTCA
GATGAAGAA-30 and PfHP1-CDXhoI 50-CCGCTCG
AGCTCATTAGCTTTCGATAAAAAATT-30 were used
to amplify a DNA fragment of 204bp that contains
PfHP1 chromodomain (CD) (PfHP1-CD). Integrity of
all recombinants clones was conﬁrmed by sequencing
with 50 and 30 primers to the pGEX cloning site (Phar-
macia). All of them were transformed into Escherichia coli
DH5a strain. Expression of GST fusion protein was
induced with 0.5mM IPTG at 308C for 4h. GST fusion
proteins were puriﬁed with glutathione sepharose
(Pharmacia) by standard methods. The PfHP1 DNA
fragment of 801bp was cloned into BamHI 50-CGGAA
TTCATGACGGGTCAGATGAAGAA-30 and NotI sites
50-ATAAGAATGCGGCCGCTTAAGCTGTACGGTA
TCTTAG-30 of the pROEX
TM HTb vector (Invitrogen).
6HisPfHP1 protein was induced in BL21 bacterial cells by
addition of 0.6mM IPTG. Recombinant proteins were
puriﬁed using nickel-nitriloacetic acid resin (TALON)
according to manufacturer protocol. Puriﬁed recombinant
proteins were veriﬁed by Western blot.
Production of PfHP1antibodies
The GST-PfHP1 recombinant protein was puriﬁed as
recommended by the manufacturers (see above). For
polyclonal antibodies against PfHP1, two rabbits were
inoculated i.c. with 100mg of GST-PfH1 protein (ﬁrst
dose). The fusion protein was emulsiﬁed with complete
adjuvant (Sigma). Following the inoculation series, ani-
mals were sacriﬁced and serum was collected. Immunoglo-
bulins were puriﬁed from serum by protein A-sepharose
(Pharmacia) chromatography, following standard
procedures.
Nuclear and cytoplasmic extracts preparation
Nuclear and cytoplasmic extracts were prepared as pre-
viously described (10,19) with some modiﬁcations.
Brieﬂy, 5 10
9 parasites of an asynchronous culture
of FCR3P. falciparum strain were isolated from infected
erythrocytes by saponin lysis, resuspended in 1ml of lysis
buﬀer (10mM HEPES, pH 7.9, 10mM KCl, 0.1mM
EDTA, 0.1mM EGTA, 1mM DTT, 0.65% NP-40)
and incubated 30min a 48C. Then, parasites were lysed
by 200 strokes on a prechilled douncer homogenizer.
The nuclei were collected by centrifugation. The super-
natant containing the cytoplasmic fraction was recovered
and kept at  808C. The nuclei were puriﬁed by sucrose
gradient centrifugation. For this purpose, the nuclei were
resuspended in 1ml of lysis buﬀer and the resulting
suspension was layered on 3ml of lysis buﬀer containing
0.34M sucrose. The nuclei were resuspended in 100mlo f
extraction buﬀer (20mM HEPES, pH 7.9, 0.4M NaCl,
1mM EDTA, 1mM EGTA and 1mM DTT). Following
15min of vigorous shaking at 48C, the extract was centri-
fuged and the supernatant containing nuclear proteins
was collected. All buﬀers used in this protocol contained
protease inhibitors (Complete, Roche).
Immunofluorescence microscopy
Immunoﬂuorescence assays were performed as previously
described (20). The parasites were ﬁxed in suspension
with 4% paraformaldehyde solution for 15min on ice.
Next, the ﬁxed parasites were incubated with the primary
antibody for 60min at room temperature followed by
incubation for 30min with a secondary antibody conju-
gated with ﬂuorochrome and deposited on microscope
slides. The ﬁnal antibody dilutions were rabbit anti-
PfHP1 1:500, rat anti-PfSir2 1:50, rat anti-PfNop1 1:50,
Alexa Fluor 568 goat anti-rabbit highly cross-absorbed
1:500 and Fluorescein-conjugated goat anti-rat
1:500.The samples were analysed in a Nikon microscope.
ChIP and dot-blots
The ChIP assay was performed as previously described
(10) with minor modiﬁcations. The parasites were treated
with saponin and cross-linked in 1% formaldehyde for
10min at 378C. Chromatin fragments were incubated
overnight at 48C with 2.5ml of rabbit polyclonal antibody
anti-PfHP1 or preimmune serum. The immunoprecipi-
tated DNA was radioactively labelled and hybridized
with a Hybond N+ membrane dot-blotted with 35ng of
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repeats as previously published (20). The 50-UTR region
of var genes (UpsB, UpsC and UpsE) were obtained as
previously described (10). For input DNA samples, an
aliquot of lysate used in the immunoprecipitation was pro-
cessed along with the rest of the samples. Quantiﬁcation
of the signal was done with the ImageQuant software
(Molecular Dynamics, Sunnyvale). The amount of
DNA immunoprecipitated in each ChIP corresponding
to the rate of the bound and input (B/I) values and
represent percentage of input.
Invitro binding assays
The His-PfHP1 protein was denatured and renatured
by dialysis against 8M urea, followed by 6M, 4M, 2M,
1M and 0.5M urea and ﬁnally with nickel-binding
buﬀer without urea. 40mg of puriﬁed His-PfHP1 fusion
protein was incubated with Nickel-nitriloacetic acid resin
(TALON) (50ml) according to manufacturer protocol.
Once the His-PfHP1 protein was immobilized on
TALON resin, it was mixed with 2mg/ml total bacterial
lysate that over-expressed GST-PfHP1 protein fusion and
incubated for 2h at 48C with 1ml binding buﬀer (20mM
Tris–HCl pH 8.0, 100mM NaCl). Next, the beads were
washed three times with 1ml washing buﬀer (20mM
Tris–HCl pH 8.0, 100mM NaCl, 15mM Imidazol
pH 8.0). Bound proteins were eluted with sample buﬀer
and boiled before loading on a SDS–PAGE gel. After
electrophoresis, proteins were transferred to Hybond
ECL nitrocellulose membrane (Amersham) as previously
described (21) and the blot was probed with anti-GST
and Anti-6His-Tag–speciﬁc antibodies. Rabbit polyclonal
antibodies against GST and polyhistidine domain
6His-probe were purchased from Santa Cruz
Biotechnology, Inc.
Dot-blotoverlay assays
The dot-blot assays were performed as described by
Sambrook et al., 1989 (22). Two hundred nanograms
of the GST-CD protein (GST-PfHP1-CD) were dotted
to Hybond ECL nitrocellulose (Amersham) and blocked
using 48C fat-free dried milk in TBS-Tween (10mM Tris–
HCl, 150mM NaCl, 1% Tween-20, pH 7.5). Membranes
were incubated overnight at 48C in BC100 buﬀer (25mM
HEPES, pH 7.6; 100mM NaCl, 1mM MgCl2, 0.5mM
EGTA, 0.1mM EDTA, 10% glycerol, 1mM DTT and
0.2mM PMSF) with 2mg or diﬀerent amounts of biotyni-
lated peptides: H3K9me3 (Upstate), H3K9me2
(Washington Biotechnology), H3K9ac (Upstate),
H3K4me3 (Upstate), H3K4me2 (Washington Biotechnol-
ogy) and non-modiﬁed H3 (Washington Biotechnology).
The membranes were washed twice (10min each) with
BC-100 plus 0.05% NP40 and twice with BC200 (25mM
HEPES, pH 7.6; 200mM NaCl, 1mM MgCl2, 0.5mM
EGTA, 0.1mM EDTA, 10% glycerol, 1mM DTT,
0.2mM PMSF and 0.05% NP-40). Membranes were
incubated with streptavidin, coupled to HRP (1:10000
dilutions in TBS plus 1% BSA) 30min at 378C. Finally
the membranes were washed seven times with TBS plus
1% Tween-20 and bound peptides were detected by
chemiluminescence using an ECL kit. Quantiﬁcation of
the signal was done with the ImageQuant software
(Molecular Dynamics, Sunnyvale).
Molecular modelling of PfHP1protein
Homology modeling of the PfCD and PfCSD complexes
was performed with MOE package (Molecular Operating
Environment, http://www.chemcomp.com) using the
crystallographic structure of CD from mouse HP1b
(19–73) and CSD from S. pombe SpSwi6 (261–320) as
template (PDB ID 1APO and 1E0B, respectively).
Search for templates and sequence alignments were done
with BLAST, with minor adjustments in the alignment
based on template structure inspection to facilitate indel
modelling. For the search of the conformation of replaced
side chains we used a library of rotamers included in
MOE; for indel modelling, a loop library of this package
was used. By random combination of these libraries we
constructed 1000 alternative models and minimized them
to reach a gradient of 0.1kcal/(mol A8). The model with
the best packing was subjected to more extensive mini-
mization, until an RMS gradient lower than 0.05kcal/
(mol A8) was obtained, and used thereafter for the struc-
tural analysis. Minimizations used the CHARMM22 force
ﬁeld with its partial-charge assignments for protein atoms.
The stereochemical quality of the model was veriﬁed with
MOE and with the Mol-Probity server (http://kinemage.
biochem.duke.edu/molprobity).
RESULTS
Identification andmodelling of theHP1 orthologue in
P. falciparum
The HP1 protein is highly preserved through evolution
from Schizosaccharomyces pombe to human, and partici-
pates in the formation of highly condensed chromatin
by recognizing the di- or tri-methylated histone H3
lysine 9 (H3K9me2 or H3K9me3) (23). In order to deter-
mine the existence of a protein similar to HP1 and its
possible participation in heterochromatin formation in
P. falciparum, we performed a search in the P. falciparum
databank (www.plasmodb.org/plasmo). This analysis
allowed us to identify the PFL1005c gene, which is
predicted to encode a 30-kDa protein. A detailed analysis
of its amino-acid sequence with the SMART program
revealed the presence of the two characteristic HP1
domains deﬁned to date: a CD located between amino
acids 6 and 60, and a low-homology chromo shadow
domain (CSD) that spans from amino acids 197–267.
Hereafter, this protein encoded by PFL1005c gene is
called PfHP1.
The P. falciparum CD’s highest identity (66%) is with
the mouse CD, while the CSD’s highest identity is with
S. pombe CSD (37%) (Figure 1A). Similar to what
has been reported in other eukaryotes, the PfHP1 CD
has three of the most conserved aromatic cage residues
(F9, W30 and Y33); in mice, these residues recognize
the H3K9me3, and abrogate silencing when they are
mutated (24).
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high similarity to that described in mouse, since it presents
the three ß chains, as well as the a2 helix structures
(Figure 1A). This suggests that PfHP1 protein might
be able to recognize the H3K9me2 and/or H3K9me3,
similarly to the HP1 protein in higher eukaryotes. With
respect to the CSD, PfHP1 consists of three beta chains
and two a helixes (a1 and a2), as described in S. pombe
and other eukaryotes. It also presents some of the residues
reported to be important for dimerization, which in turn
are necessary for heterochromatin formation (Figure 1A).
In order to determine whether the CD and CSD
domains of the PfHP1 protein have a tertiary structure
similar to that described in S. pombe and other eukaryotes,
we made homology models, taking as a reference the
mouse HP1 CD domain and Swi6 protein CSD of
S. pombe. The tertiary structure obtained showed that
PfHP1 CD and CSD domains have a folding similar to
that of the mouse CD and S. pombe CSD (Figure 1B).
Dimer formation in S. pombe is centred on helix 2,
which interacts symmetrically with the helix 2 of the
other monomer, and the primary contacts involve amino
acids L161, Y164 and L168. In PfHP1, L161 and L168 are
present, but Y164 has been replaced by a L. Nevertheless,
in mouse Y164 has also been changed and that does not
aﬀect dimer formation (25). Therefore, amino acids L161,
L164 and L168 could play a role in PfHP1 dimer forma-
tion (Figures 1C–C2). In the case of S. pombe, it has been
found that the bonding of the two monomers through the
alpha 2 helix generates a hydrophobic groove that favours
protein–protein interactions (25). As seen in Figure 1C,
the PfHP1 CSD folding generates a hydrophobic groove
through which the PfHP1 monomers can interact with
themselves. Finally, the overlap of S. pombe CSD homo-
dimers (magenta–yellow) and CSD of PfHP1 (red–green)
showed similar structural organization (Figure 1D).
In conclusion, the predicted tertiary structure suggests
that PfHP1 might interact with histone H3 lysine
9 methylated, as well as participate in the formation of
homodimers.
Invitro binding ofthe PfHP1CD to H3K9me2
andH3K9me3 peptides
The CD in eukaryotes is responsible for recognizing
H3K9me2 or H3K9me3 (26,27). To determine whether
the PfHP1 protein is able to perform the same function
Figure 1. Structural modelling of the chromo domain (CD) and chromoshadow domain (CSD) of PfHP1. (A) Schematic diagram showing the
complete ORF and location of CD and CSD of PfHP1 separated by the hinge. Numbers correspond to residue positions for each domain. The
primary sequence alignment of CD from mouse HP1ß (19–73 aa) and PfHP1 (6–60 aa) was used for the modelling of the CD domain.
The boxes indicate the aromatic cage residues potentially involved in the recognition of the H3K9me peptide. Conserved residues that form a
complementary surface responsible for H3 peptide recognition in the CD from Drosophila are indicated in red (24). The primary sequence alignment
of CSD from S. pombe (261–320 aa) and from PfHP1 (197–267 aa) was used to perform the model of the CSD domains. Residues implicated in the
formation of the dimer interface are enclosed in boxes. Residues that have shown to be important for dimer formation in S. pombe (25) are indicated
with pink letters. Both alignments were performed with ClustalW and used for modelling with the program MOE (www.chemcomp.com). The
secondary structure elements are shown above the alignment: bars represent a-helices (a-1 and a-2) and arrows represent b-strands (b1–b3). (B)
Tertiary structure of CD and CSD domains of PfHP1. The structure is conserved between mouse and P. falciparum CD domains, and between S.
pombe and P. falciparum CSD domains. (C) Cartoon representation of the CSD dimer. The two monomers are indicated in red. The molecular
surface of the putative PfHP1-CSD dimer is shown. (C1) A putative monomer is shown by cartoon and the other one by molecular surface. Surface
convex zones are shown in red (protuberances); concave zones that correspond to binding or recognition sites are shown in green (hydrophobic
regions) and the polar surface is denoted in blue. (C2) The hydrophobic region and the crucial L residues that contact the other subunit in the
formation of the dimer are indicated. (D) Superposition of the 3D models of the CSD domains homodimers from Swi6 (magenta–yellow) and PfHP1
homodimers (green–red). The CSD architecture is strongly conserved between S. pombe and P. falciparum.
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ponding to the CD was produced. This protein was pur-
iﬁed and immunoblotted with anti-GST antibodies
(Figure 2A). A band of the predicted size (33kDa) was
observed together with minor bands, which are probably
degradation products often seen for GST fusion proteins.
The GST-PfHP1-CD protein was then used to investigate
its binding speciﬁcity to diﬀerent histone modiﬁcations.
The GST-PfHP1-CD protein was dotted on nylon mem-
branes and incubated with the following biotinylated his-
tone H3 peptides: H3K9me3, H3K9me2, H3K9ac,
H3K4me3, H3K4me2 and unmodiﬁed histone H3.
Binding of the peptides to the CD of PfHP1 was detected
using streptavidin conjugated to HRP. Signal was
observed only with H3K9me2 and H3K9me3
(Figure 2B). To show that the modiﬁed histone H3 pep-
tides did not bind the recombinant GST-CD protein
through GST, the GST protein was used as a negative
control (data not shown). These results demonstrate that
the CD from PfHP1 protein is able to interact to
H3K9me2 and H3K9me3, but not to H3K9ac,
H3K4me2, H3K4me3 or to unmodiﬁed histone H3.
To determine the aﬃnity of the GST-PfHP1-CD protein
for both H3K9me3 and H3K9me2 peptides, dot blot bind-
ing-assays were performed using a ﬁxed amount of GST-
PfHP1-CD fusion protein with diﬀerent concentrations
of peptides. Densitometry analysis showed that in vitro
GST-PfHP1-CD binds three times more eﬃciently to
H3K9me3 than to H3K9me2 (Figure 2C).
Recombinant PfHP1forms homodimers
Cowieson et al. demonstrated that recombinant CSD in its
unmodiﬁed form is able to dimerize in solution through
the alpha helixes, forming a non-polar cavity where pro-
teins that have the P V L pentapeptide can bind (28).
To demonstrate that PfHP1 is able to form dimers as
suggested by the tertiary structure, we generated recombi-
nant PfHP1 proteins fused to GST (GST-PfHP1) and to
six histidines (His-PfHP1). Inclusion bodies containing
His-PfHP1 were incubated in the presence of urea, rena-
tured and incubated with Nickel-beads. These beads were
washed and the bound protein was eluted, analysed by
SDS–PAGE, blotted and tested with the anti-histidine
antibodies. These antibodies recognized a 33kDa protein,
which corresponds to the monomeric form of PfHP1
(Figure 3A).
We next incubated lysates from bacterial cells over-
expressing the GST-PfHP1 fusion protein (55kDa)
with the renatured His-PfHP1 fusion protein bound to
the nickel beads. Bound proteins were eluted, separated
by SDS–PAGE and immunoblotted with anti-histidine
and anti-GST antibodies (Figure 3B). The Western blot
analysis conﬁrmed that His-PfHP1 interacts speciﬁcally
with GST-PfHP1. GST alone (26kDa) did not bind to
His-PfHP1 under the same conditions (Figure 3B).
Similar results were obtained when we used puriﬁed
GST-PfHP1 and His-PfHP1 fusion proteins in the pull-
down assays (data not shown). In summary, our in vitro
experiments suggest the ability of PfHP1 to form dimers,
which appears to be important for HP1-mediated hetero-
chromatin formation (see model in Figure 6A).
PfHP1 localizes atthe nuclear periphery
To further investigate the function of PfHP1, we raised
polyclonal antibodies against the recombinant GST-
PfHP1. Immunoblot analysis of parasite nuclear extracts
Figure 2. PfHP1 binds to histone H3 peptide methylated at lysine 9. (A) Total proteins from DH5a strain expressing the CD of PfHP1 before (NI)
and after IPTG induction (I), as well as the puriﬁed GST-PfHP1-CD fusion protein (P), were separated by SDS–PAGE and stained with Coomassie
blue (left). An anti-GST antibody was used to detect the presence of the fusion protein (right). (B) Puriﬁed protein GST-PfHP1-CD was assayed for
binding to histone H3 peptides. 200ng of GST-CD protein (GST-PfHP1-CD) were dotted to a nitrocellulose membrane and incubated with 2mgo f
the following biotinylated peptides: H3K9me3, H3K9me2, H3K9ac, H3K4me3, H3K4me2 and unmodiﬁed H3. (C) Two hundred nanograms of
GST-PfHP1-CD fusion protein were dotted to nitrocellulose and incubated with decreasing amounts of H3K9me3 and H3K9me2 biotinylated
peptides (left panels). A representative result of two independent experiments is shown. The right panel shows a quantitative presentation of the
GST-PfHP1-CD aﬃnity to the peptides.
2600 Nucleic Acids Research, 2009, Vol. 37,No. 8with this anti-GST-PfHP1 antibody detected a 30kDa
protein, which has the predicted size of PfHP1. The
speciﬁcity of the nuclear extracts was veriﬁed using an
anti-acetyl histone H4 antibody, which recognizes both
histones H2B and H4 (Figure 4A). No signal was
detected in the cytoplasmic fraction (data not shown).
Preimmune serum and anti-GST antibody gave no signal
with the parasite’s nuclear extracts (Figure 4A).
To study the subnuclear location of PfHP1, we per-
formed immunoﬂuorescence assays (IFA) in diﬀerent
Figure 4. Nuclear expression and cellular localization of PfHP1. (A) Western blot analysis of nuclear extracts from P. falciparum using the following
antibodies: anti-GST antibody (left), preimmune serum, anti-GST-PfHP1 antibody (middle) and anti-acetyl histone 4 antibodies (right). (B) IFA
analysis of PfHP1 (green) throughout the parasite asexual blood stage cycle (ring, trophozoite and schizont stages). (C) In ring stage, partial
co-localization between PfHP1 (red) and PfSir2 (green) antibodies (yellow spots) is observed. (D) Co-localization with a nucleolar marker
PfNop1 shows minimal overlap of PfHP1 with this compartment. Scale bars represent 1mm.
Figure 3. In vitro dimerization of the PfHP1 protein. (A) His-PfHP1 protein puriﬁed using nickel-nitriloacetic acid resin (left). Western blot analysis
with anti-histidine antibodies identiﬁed the monomer of PfHP1 (right). (B) Interaction between His-PfHP1 ( 30kDa) and GST-PfHP1 fusion
proteins ( 55kDa). Puriﬁed His-PfHP1 was mixed with total bacterial lysate overexpressing GST-PfHP1 fusion protein (left panels) or only GST
(right panels). Protein complexes were recovered, separated by SDS–PAGE and detected by Western blot with anti-histidine and anti-GST antibodies.
Nucleic Acids Research,2009, Vol.37, No. 8 2601stages of the 48-h asexual cycle. PfHP1 appears to form
nuclear foci during the entire cycle (Figure 4B). In ring
stages ( 16h), PfHP1 locates predominantly to peri-
nuclear space, whereas in trophozoite stages ( 30h) and
schizonts ( 40h) the number of foci increases and seems
to redistribute in the nucleoplasm.
To test whether PfHP1 localizes to telomeric perinuclear
clusters we performed dual IFA using anti-PfHP1 and
anti-Sir2 antibodies. We observed that PfHP1 localizes
with some PfSir2 ﬂuorescent signals (Figure 4C). Because
PfSir2 is not an exclusive marker for telomeric clusters and
anti-PfSir2 also stains the nucleolus (10), we carried out a
dual IFA using an antibody against a nucleolar protein
(anti-PfNop1). We observed that PfHP1 did not (or
only marginally) co-localize with the nucleolar marker
(Figure 4D), indicating that the PfHP1 foci co-localizing
with PfSir2 correspond indeed to telomeric foci.
PfHP1 binds tosubtelomeric TAREs and isimplicated
in thecontrol ofvar genesexpression
The IFA suggested that the PfHP1 protein is located on
the telomeric and/or subtelomeric regions of P. falciparum.
To determine the in vivo distribution of PfHP1 over the
chromosome ends of the parasite, we performed ChIP
assays. DNA pulled down with anti-GST-PfHP1 was
hybridized to diﬀerent repetitive TARE elements and telo-
mere probes in a dot blot assay. We observed that PfHP1
is enriched in the subtelomeric region and almost absent
in the telomeric repeats (Figure 5B). A single copy
Figure 5. PfHP1 is associated to constitutive and facultative heterochromatin. (A) Schematic representation of telomeric and subtelomeric regions of
P. falciparum. In this parasite, chromosome ends are composed of telomeres and telomere associated repetitive elements (TAREs 1–6). The
subtelomeric coding region contains members of several multigene families important for virulence, such as the var genes. The var gene repertoire
is classiﬁed in diﬀerent types according to the conserved upstream sequences. Ups A, B and E types are located on subtelomeric regions, whereas
UpsC types are found in central chromosomal position. The positions of the probes used in ChIP assays are shown. (B) Dot blot based ChIP analysis
of PfHP1 abundance at telomeric and non-coding subtelomeric regions. DNA probes corresponding to TARE 1, 2, 3, 6 and a sequence between
TARE 2–3 were ﬁxed to nylon membranes and hybridized to DNA immunoprecipitated with anti-PfHP1 antibodies and preimmune serum (PI) (left
panels). The 50-UTR region of the histidine rich protein 1 (HRP1) gene, expressed during blood stage, was used as control (left panels). (C) ChIP
analysis of FCR3-CSA parasites, in which the var2CSA gene is active (UpsE ON). (D) ChIP analysis of FCR3-CD36 parasites, in which the
var2CSA gene is repressed (UpsE OFF). In (C) and (D) DNA corresponding to diﬀerent types of var 50-UTR regions (UpsE, UpsC and UpsB),
50-UTR region of HRP1 and TARE6 were ﬁxed on nylon membranes and hybridized to DNA immunoprecipitated with anti-PfHP1 antibodies and
PI serum (left panels). The right panels show a quantitative representation of PfHP1 levels at the diﬀerent DNA regions. In all cases, ChIP analysis
was performed in ring stage parasites and a representative result is shown. Error bars represent the standard deviation from three independent
experiments each performed in duplicate. Input corresponds to DNA prepared from fragmented chromatin prior to immunoprecipitation.
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pitate with the anti-GST-PfHP1 antibody (Figure 5B).
These results show that PfHP1 is associated to chromatin
across subtelomeric repeat elements, most likely mediating
chromatin compaction.
To determine whether PfHP1 has a role in the silencing
of subtelomeric var genes, we performed ChIP assays
using two isogenic parasite populations: FCR3-CSA that
expresses a speciﬁc subtelomeric var gene (var2CSA), and
FCR3-CD36 in which the same gene is repressed. We
found that the var2CSA upstream region (UpsE) is immu-
noprecipitated by anti-GST-PfHP1 antibodies when this
gene is inactive (FCR3-CD36 population, Figure 5D)
but not when it is active (FCR3-CSA population,
Figure 5C). Other types of var gene upstream regions
representing subtelomeric and chromosome central var
members (UpsB and UpsC, respectively), which are in
a repressed state in these parasite populations, were
immunoprecipitated by anti-PfHP1 antibodies. Thus,
our data show that PfHP1 is linked to repression of
subtelomeric but also to central var genes.
DISCUSSION
In this work, we identiﬁed and characterized PfHP1, the
ﬁrst protein from P. falciparum that binds speciﬁcally to
a histone modiﬁcation, thus demonstrating the existence
of histone-mark-reading machinery in this pathogen. Our
in vitro results demonstrated that PfHP1 speciﬁcally
recognizes H3K9me2 and H3K9me3 peptides by its
CD. The aﬃnity of this protein seems to be greater for
tri-methylated than for di-methylated peptide (Figure 2C),
suggesting that the degree of methylation at histone H3K9
may lead to the formation of more or less tight chromatin.
As predicted by its tertiary structure (Figure 1), PfHP1
is able to interact with itself (Figure 3B), which suggests
a role in the formation and maintenance of heterochroma-
tin, similarly to its orthologues in S. pombe, Drosophila
and human (29). Furthermore, our data reinforce the
idea that the machinery involved in heterochromatin
formation in Plasmodium is more similar to metazoa
than to S. cerevisiae. It also shows that the HP1 protein
is not exclusive of metazoan, as it has been proposed (30).
Nuclear staining with anti-PfHP1 suggested that this
protein is located at the perinuclear region visible as
foci similar to PfSir2 and PfOrc1, two proteins known
to be components of subtelomeric heterochromatin in
P. falciparum (10,20). In contrast to PfSir2 and PfOrc1,
our co-localization experiments demonstrated that PfHP1
does not stain the parasite nucleolus and may therefore
not participate in the silencing of rDNA genes in blood
stage parasites.
The notion that PfHP1 is a component of telomeric
heterochromatin was further demonstrated by showing
the binding of PfHP1 to subtelomeric chromatin
(Figure 5). ChIP studies clearly showed that the anti-
PfHP1 antibody immunoprecipitated subtelomeric regions
as well as members of the var gene family, and react
poorly with telomeric repeats. Like in yeast, the telomeres
of P. falciparum are mostly not packed in nucleosomes
whereas the subtelomeric chromatin contains nucleosomes
(31). The association of PfHP1 with the subtelomeric
chromatin correlates well with the nucleosomal nature of
HP1 heterochromatinization function.
Importantly, our data show that PfHP1 protein is
linked to monoallelic expression of the major virulence
gene family in this human pathogen. The data strongly
suggest that PfHP1 must be removed from the var
upstream regions to allow gene expression. Our ChIP
assays demonstrated that PfHP1 is able to bind not only
to subtelomeric but also to central var genes (Figure 5).
Consistent with these results, P. falciparum genome-wide
high-resolution ChIP analysis of histone mark H3K9me3
shows a restricted localization to telomeres, subtelomeres
and internal chromosomal regions that contain virulence
gene families (Lopez-Rubio, JJ and Scherf A. personal
communication). It is very likely that PfHP1 displays
a genome-wide distribution similar to H3K9me3. The pre-
sence of PfHP1 in internal chromosomal domains may
explain the partial co-localization with telomeric PfSir2
foci in the IFA analysis.
In mammals, the HP1 family is composed of three
variants (alpha, beta and gamma), which are coded
by distinct genes (32). These proteins are involved in
diﬀerent events: HP1 alpha and beta in heterochromatin
formation, and HP1 gamma in euchromatin formation
(29). We have found only one hp1 gene in P. falciparum
genome and this one was conﬁrmed by Southern blot
analysis (data not shown). This raises the question
of whether a single PfHP1 protein performs diﬀerent
functions. The hinge region of HP1 protein is highly
amenable to post-translational modiﬁcations especially
phosphorylation (29). In addition, mutations in this
region have been shown to aﬀect the location, interactions
and functions of HP1 (33). For example, Ser83 phosphor-
ylation of HP1 gamma is important for its localization
only in euchromatic regions (34). In silico analysis of
PfHP1 protein indicates that a number of post-transla-
tional changes, such as: sumoylation, ubiquitination and
phosphorylation, may occur mainly in the hinge region
(Perez-Toledo K and Hernandez-Rivas R unpublished
data). It is therefore possible that diﬀerent post-transla-
tional modiﬁcations may deﬁne distinct functions of
PfHP1. Another component of the subtelomeric chroma-
tin, PfSir2, has recently been shown to be sumoylated (35).
It will be interesting to investigate whether mutation in the
PfHP1 hinge region will aﬀect function and nuclear
location.
PfHP1 knock-out parasites would be a valuable tool
to further investigate the role in gene silencing in
P. falciparum. So far, all our attempts to disrupt the hp1
gene had failed. This is possibly due to the fact that
only one copy exists in the genome. It may also be due
to additional essential roles of PfHP1 possibly related
with chromosome integrity and/or nuclear organization
in this parasite. Inducible loss-of-function systems
appear now to be available for P. falciparum that may
allow PfHP1 phenotype analysis (36).
In line with our data, we propose a model in
which PfHP1 works in concert with a histone deacetylase
and a histone methyltransferase in heterochromatin
Nucleic Acids Research,2009, Vol.37, No. 8 2603formation (Figure 6A). In our model, a histone deacety-
lase PfSir2 (10,37), is ﬁrst recruited to chromatin and
deacetylates H3K9 residues. In a subsequent step, we
hypothesize that the H3K9 methyltransferase orthologue
PfKMT1 (15) methylates the H3K9 residues. As a con-
sequence, PfHP1 binds to H3K9me3, dimerizes and pro-
motes chromatin condensation. This leads to PfHP1
spreading into the coding regions, thus contributing to
the reversible silencing of virulence factor gene families
immediately adjacent of TAREs (Figure 6B). What
recruits PfHP1 to central var genes remains guesswork.
In mammals, targeting of HP1 to chromatin requires
not only K9 methylation but also a direct protein–protein
interaction with SUV39 (an orthologue of PfKMT1)
(38). HP1 can also interact with Orc1, as it has been
demonstrated in Drosophila and Xenopus (39,40). The
spreading of PfHP1 along the diﬀerent TAREs is most
likely controlled by complex machinery including known
components such as PfSir2, PfOrc1 and PfKMT1. Further
studies are necessary to determine potential protein–
protein interaction between PfHP1 and other chromatin
components by TAP-tag or pull down assays.
In conclusion, this work identiﬁes a key component
of the epigenetic machinery involved in heterochromatin
formation. We demonstrated that PfHP1 is closely related
to its counterpart in higher eukaryotes, since it is able to
form homodimers and binds methylated histone H3K9.
PfHP1 is the ﬁrst plasmodial protein identiﬁed that recog-
nizes a speciﬁc histone modiﬁcation, which is linked gene
silencing of virulence factor gene families located adjacent
to TAREs and some chromosome internal regions. Upon
activation of a single gene member in a mutually exclusive
fashion, PfHP1 is absent of the promoter region of the
activated gene. This is a major conceptual advance to
our knowledge and may have a big impact on the allelic
exclusion ﬁeld in other pathogens and higher eukaryotes.
Together with the previously identiﬁed PfSir2, PfHP1
might form the core of the subtelomeric heterochromatin
machinery in P. falciparum. Our anti-PfHP1 antibodies
are a new tool to investigate facultative and constitutive
heterochromatin formation in malaria parasites.
Telomere-linked control of phenotypic variation is an
important issue in malaria pathogenesis and a better
knowledge of the epigenetic factors controlling those is
vital for understanding the disease and to develop new
anti-parasite control strategies.
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